MET and ovarian clear cell adenocarcinoma: Overexpression of HGF and/or c-Met has been associated with poor clinical outcome in OVCA (5–7), whereas c-Met overexpression has further been associated with a chemo-resistant subset of ovarian clear-cell adenocarcinomas (8,9).